PR Newswire Clinical TrialsOriginal article
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
PartnershipPositive
AI Analysis
Summary
Evotec and Odyssey Therapeutics announced an AI-enabled R&D collaboration combining Odyssey's disease biology expertise with Evotec's AI discovery platform and screening capabilities to advance discovery-stage autoimmune and inflammatory disease programs.
Importance:6/10
Sentiment:
0.60
partnershipcollaborationAI-enabled discoveryautoimmune diseasesinflammatory diseasesdrug discovery
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on August 6, 2026 6:16 AM